Related Experiment Videos
New minimum length requirement for a T cell epitope for experimental allergic neuritis
T Olee1, H C Powell, S W Brostoff
1Immune Response Corporation, San Diego, CA 92121.
Journal of Neuroimmunology
|May 1, 1990
Summary
Researchers identified a specific peptide sequence (residues 61-70) from the bovine P2 protein as the minimum requirement for inducing experimental allergic neuritis (EAN). Enhancing this peptide further increased its ability to cause EAN in rats.
Area of Science:
- Neuroscience
- Immunology
- Protein Chemistry
Background:
- Experimental allergic neuritis (EAN) is an animal model for Guillain-Barré syndrome.
- The bovine P2 protein is known to induce EAN in susceptible animals.
- Identifying specific T cell epitopes is crucial for understanding autoimmune disease pathogenesis.
Purpose of the Study:
- To determine the minimum peptide sequence of the bovine P2 protein responsible for inducing EAN.
- To investigate the role of specific amino acid residues in T cell epitope recognition and disease induction.
- To enhance the neuritogenic capability of identified P2 protein peptides.
Main Methods:
- Synthesis of overlapping peptides representing regions of the bovine P2 protein.
- Generation and utilization of P2-specific T cell lines.
- Assay of neuritogenic activity of synthetic peptides in Lewis rats.
Main Results:
- The minimal T cell epitope for EAN induction was identified as residues 61-70 (EISFKLGQEF) of the P2 protein.
- This 10-amino acid peptide sequence was sufficient to elicit EAN.
- Adding a threonine residue at the NH2 terminus (residues 60-70) significantly enhanced the peptide's neuritogenic capability.
Conclusions:
- The P2 protein residues 61-70 constitute the minimum T cell epitope for EAN induction.
- Peptide modifications, such as N-terminal extension, can modulate epitope potency.
- These findings provide insights into the molecular basis of P2-induced autoimmune neuritis and potential therapeutic targets.